AAAAAA

   
Results: 1-25 | 26-44 |
Results: 26-44/44
ASSESSMENT OF THE PHARMACOKINETIC-PHARMACODYNAMIC INTERACTION BETWEENTERAZOSIN AND FINASTERIDE
Authors: SAMARA EE HOSMANE B LOCKE C EASON C CAVANAUGH J GRANNEMAN GR
Citation: Ee. Samara et al., ASSESSMENT OF THE PHARMACOKINETIC-PHARMACODYNAMIC INTERACTION BETWEENTERAZOSIN AND FINASTERIDE, Journal of clinical pharmacology, 36(12), 1996, pp. 1169-1178
A SINGLE-DOSE STUDY TO DEFINE THE PHARMACOKINETICS OF TIAGABINE IN PEDIATRIC-PATIENTS
Authors: GUSTAVSON LE GUENTHER HJ BOELLNER SW GRANNEMAN GR SOMMERVILLE KW
Citation: Le. Gustavson et al., A SINGLE-DOSE STUDY TO DEFINE THE PHARMACOKINETICS OF TIAGABINE IN PEDIATRIC-PATIENTS, Neurology, 46(2), 1996, pp. 2025-2025
EFFECTS OF DIVALPROEX SODIUM ON AMITRIPTYLINE AND NORTRIPTYLINE PHARMACOKINETICS
Authors: WONG SL CAVANAUGH J SHI H AWNI WM GRANNEMAN GR
Citation: Sl. Wong et al., EFFECTS OF DIVALPROEX SODIUM ON AMITRIPTYLINE AND NORTRIPTYLINE PHARMACOKINETICS, Clinical pharmacology and therapeutics, 60(1), 1996, pp. 48-53
ASSESSMENT OF THE PHARMACOKINETIC INTERACTION BETWEEN RITONAVIR(R) AND CLARITHROMYCIN
Authors: OUELLET D HSU A GRANNEMAN GR CARLSON G GUENTHER H MUKHERJEE D LOCKE C LEONARD JM
Citation: D. Ouellet et al., ASSESSMENT OF THE PHARMACOKINETIC INTERACTION BETWEEN RITONAVIR(R) AND CLARITHROMYCIN, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 58-58
EFFECT OF RENAL IMPAIRMENT ON THE PHARMACOKINETICS OF A NEW DOPAMINERGIC SELECTIVE ANTIPSYCHOTIC COMPOUND
Authors: WONG SL SEBREE T MENACHERRY S MULFORD D LINNEN P GRANNEMAN GR
Citation: Sl. Wong et al., EFFECT OF RENAL IMPAIRMENT ON THE PHARMACOKINETICS OF A NEW DOPAMINERGIC SELECTIVE ANTIPSYCHOTIC COMPOUND, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 108-108
DETERMINATION OF LANSOPRAZOLE AND 5 METABOLITES IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
Authors: KAROL MD GRANNEMAN GR ALEXANDER K
Citation: Md. Karol et al., DETERMINATION OF LANSOPRAZOLE AND 5 METABOLITES IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 668(1), 1995, pp. 182-186
PHARMACOKINETIC INTERACTION BETWEEN LANSOPRAZOLE AND THEOPHYLLINE
Authors: GRANNEMAN GR KAROL MD LOCKE CS
Citation: Gr. Granneman et al., PHARMACOKINETIC INTERACTION BETWEEN LANSOPRAZOLE AND THEOPHYLLINE, Therapeutic drug monitoring, 17(5), 1995, pp. 460-464
POPULATION PHARMACOKINETICS OF ZILEUTION, A SELECTIVE 5-LIPOXYGENASE INHIBITOR, IN PATIENTS WITH RHEUMATOID-ARTHRITIS
Authors: AWNI WM GRANNEMAN GR LOCKE CS BRANDWEIN SR DUBE LM
Citation: Wm. Awni et al., POPULATION PHARMACOKINETICS OF ZILEUTION, A SELECTIVE 5-LIPOXYGENASE INHIBITOR, IN PATIENTS WITH RHEUMATOID-ARTHRITIS, European Journal of Clinical Pharmacology, 48(2), 1995, pp. 155-160
THE EFFECT OF ZILEUTON ON ANTIPYRINE AND INDOCYANINE GREEN DISPOSITION
Authors: STPETER JV BRAECKMAN RA GRANNEMAN GR LOCKE CS CAVANAUGH JH AWNI WM
Citation: Jv. Stpeter et al., THE EFFECT OF ZILEUTON ON ANTIPYRINE AND INDOCYANINE GREEN DISPOSITION, Clinical pharmacology and therapeutics, 57(3), 1995, pp. 299-308
PHARMACOKINETICS OF MULTIPLE ORAL DOSE DIVALPROEX SODIUM AFTER INTRAVENOUS LOADING DOSE ADMINISTRATION IN HEALTHY-VOLUNTEERS
Authors: CAVANAUGH JH HUSSEIN Z LAMM J GRANNEMAN GR
Citation: Jh. Cavanaugh et al., PHARMACOKINETICS OF MULTIPLE ORAL DOSE DIVALPROEX SODIUM AFTER INTRAVENOUS LOADING DOSE ADMINISTRATION IN HEALTHY-VOLUNTEERS, Drug investigation, 7(1), 1994, pp. 1-7
PHARMACOKINETICS OF VALPROATE AFTER MULTIPLE-DOSE ORAL AND INTRAVENOUS-INFUSION ADMINISTRATION - GASTROINTESTINAL-RELATED DIURNAL-VARIATION
Authors: HUSSEIN Z MUKHERJEE D LAMM J CAVANAUGH JH GRANNEMAN GR
Citation: Z. Hussein et al., PHARMACOKINETICS OF VALPROATE AFTER MULTIPLE-DOSE ORAL AND INTRAVENOUS-INFUSION ADMINISTRATION - GASTROINTESTINAL-RELATED DIURNAL-VARIATION, Journal of clinical pharmacology, 34(7), 1994, pp. 754-759
CHARACTERIZATION OF THE PHARMACOKINETICS AND PHARMACODYNAMICS OF A NEW ORAL THROMBOXANE A(2)-RECEPTOR ANTAGONIST AA-2414 IN NORMAL SUBJECTS- POPULATION ANALYSIS
Authors: HUSSEIN Z SAMARA E LOCKE CS ORCHARD MA RINGHAM GL GRANNEMAN GR
Citation: Z. Hussein et al., CHARACTERIZATION OF THE PHARMACOKINETICS AND PHARMACODYNAMICS OF A NEW ORAL THROMBOXANE A(2)-RECEPTOR ANTAGONIST AA-2414 IN NORMAL SUBJECTS- POPULATION ANALYSIS, Clinical pharmacology and therapeutics, 55(4), 1994, pp. 441-450
DIURNAL-VARIATION IN THE PHARMACOKINETICS OF ZILEUTON IN HUMANS
Authors: AWNI WM CAVANAUGH JH GRANNEMAN GR SCHNECK DW DUBE LM
Citation: Wm. Awni et al., DIURNAL-VARIATION IN THE PHARMACOKINETICS OF ZILEUTON IN HUMANS, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 199-199
AGE-RELATED DIFFERENCES IN THE PHARMACOKINETICS AND PHARMACODYNAMICS OF LANSOPRAZOLE
Authors: HUSSEIN Z GRANNEMAN GR MUKHERJEE D SAMARA E HOGAN DL KOSS MA ISENBERG JI
Citation: Z. Hussein et al., AGE-RELATED DIFFERENCES IN THE PHARMACOKINETICS AND PHARMACODYNAMICS OF LANSOPRAZOLE, British journal of clinical pharmacology, 36(5), 1993, pp. 391-398
STEREOSELECTIVE PHARMACOKINETICS OF PAZINACLONE, A NEW NONBENZODIAZEPINE ANXIOLYTIC, AND ITS ACTIVE METABOLITE IN HEALTHY-SUBJECTS
Authors: HUSSEIN Z MULFORD DJ BOPP BA GRANNEMAN GR
Citation: Z. Hussein et al., STEREOSELECTIVE PHARMACOKINETICS OF PAZINACLONE, A NEW NONBENZODIAZEPINE ANXIOLYTIC, AND ITS ACTIVE METABOLITE IN HEALTHY-SUBJECTS, British journal of clinical pharmacology, 36(4), 1993, pp. 357-361
SIMULTANEOUS MODELING OF THE PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES OF ENALKIREN (ABBOTT-64662, A RENIN INHIBITOR) .2. A DOSE-RANGING STUDY IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
Authors: GUPTA SK GRANNEMAN GR PACKER M BOGER RS
Citation: Sk. Gupta et al., SIMULTANEOUS MODELING OF THE PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES OF ENALKIREN (ABBOTT-64662, A RENIN INHIBITOR) .2. A DOSE-RANGING STUDY IN PATIENTS WITH CONGESTIVE-HEART-FAILURE, Journal of cardiovascular pharmacology, 21(5), 1993, pp. 834-840
EFFECT OF INFUSION DURATION ON VALPROATE PHARMACOKINETICS
Authors: HUSSEIN Z PATTERSON KJ LAMM JE CAVANAUGH JH GRANNEMAN GR
Citation: Z. Hussein et al., EFFECT OF INFUSION DURATION ON VALPROATE PHARMACOKINETICS, Biopharmaceutics & drug disposition, 14(5), 1993, pp. 389-399
EFFECT OF MODERATE OR SEVERE HEPATIC IMPAIRMENT ON CLARITHROMYCIN PHARMACOKINETICS
Authors: CHU SY GRANNEMAN GR PICHOTTA PJ DECOURT JP GIRAULT J FOURTILLAN JB
Citation: Sy. Chu et al., EFFECT OF MODERATE OR SEVERE HEPATIC IMPAIRMENT ON CLARITHROMYCIN PHARMACOKINETICS, Journal of clinical pharmacology, 33(5), 1993, pp. 480-485
DIFFERENCES IN THE STEREOSELECTIVE PHARMACOKINETICS OF PAZINACLONE (DN-2327), A NEW ANXIOLYTIC, AND ITS ACTIVE METABOLITE AFTER INTRAVENOUSAND ORAL SINGLE DOSES TO DOGS
Authors: HUSSEIN Z MULFORD DJ BOPP BA GRANNEMAN GR
Citation: Z. Hussein et al., DIFFERENCES IN THE STEREOSELECTIVE PHARMACOKINETICS OF PAZINACLONE (DN-2327), A NEW ANXIOLYTIC, AND ITS ACTIVE METABOLITE AFTER INTRAVENOUSAND ORAL SINGLE DOSES TO DOGS, Drug metabolism and disposition, 21(5), 1993, pp. 805-810
Risultati: 1-25 | 26-44 |